Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global mRNA Vaccine Market Size Growth Rate by Type
1.3.2 Standardization Of Cancer Treatment MRNA Vaccine
1.3.3 Individualized Cancer Treatment MRNA Vaccine
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Market Segment by Application
1.4.1 Global mRNA Vaccine Market Share by Application (2018-2025)
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccine Market Size
2.1.1 Global mRNA Vaccine Revenue 2013-2025
2.1.2 Global mRNA Vaccine Sales 2013-2025
2.2 mRNA Vaccine Growth Rate by Regions
2.2.1 Global mRNA Vaccine Sales by Regions 2013-2018
2.2.2 Global mRNA Vaccine Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 mRNA Vaccine Sales by Manufacturers
3.1.1 mRNA Vaccine Sales by Manufacturers 2013-2018
3.1.2 mRNA Vaccine Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 mRNA Vaccine Revenue by Manufacturers (2013-2018)
3.2.2 mRNA Vaccine Revenue Share by Manufacturers (2013-2018)
3.2.3 Global mRNA Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 mRNA Vaccine Price by Manufacturers
3.4 Key Manufacturers mRNA Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into mRNA Vaccine Market
3.6 Key Manufacturers mRNA Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Standardization Of Cancer Treatment MRNA Vaccine Sales and Revenue (2013-2018)
4.1.2 Individualized Cancer Treatment MRNA Vaccine Sales and Revenue (2013-2018)
4.1.3 Infectious Disease Treatment MRNA Vaccine Sales and Revenue (2013-2018)
4.1.4 Infection Prevention MRNA Vaccine Sales and Revenue (2013-2018)
4.2 Global mRNA Vaccine Sales Market Share by Type
4.3 Global mRNA Vaccine Revenue Market Share by Type
4.4 mRNA Vaccine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global mRNA Vaccine Sales by Application
6 North America
6.1 North America mRNA Vaccine Breakdown Data by Company
6.2 North America mRNA Vaccine Breakdown Data by Type
6.3 North America mRNA Vaccine Breakdown Data by Application
6.4 North America mRNA Vaccine Breakdown Data by Countries
6.4.1 North America mRNA Vaccine Sales by Countries
6.4.2 North America mRNA Vaccine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe mRNA Vaccine Breakdown Data by Company
7.2 Europe mRNA Vaccine Breakdown Data by Type
7.3 Europe mRNA Vaccine Breakdown Data by Application
7.4 Europe mRNA Vaccine Breakdown Data by Countries
7.4.1 Europe mRNA Vaccine Sales by Countries
7.4.2 Europe mRNA Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific mRNA Vaccine Breakdown Data by Company
8.2 Asia Pacific mRNA Vaccine Breakdown Data by Type
8.3 Asia Pacific mRNA Vaccine Breakdown Data by Application
8.4 Asia Pacific mRNA Vaccine Breakdown Data by Countries
8.4.1 Asia Pacific mRNA Vaccine Sales by Countries
8.4.2 Asia Pacific mRNA Vaccine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America mRNA Vaccine Breakdown Data by Company
9.2 Central & South America mRNA Vaccine Breakdown Data by Type
9.3 Central & South America mRNA Vaccine Breakdown Data by Application
9.4 Central & South America mRNA Vaccine Breakdown Data by Countries
9.4.1 Central & South America mRNA Vaccine Sales by Countries
9.4.2 Central & South America mRNA Vaccine Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccine Breakdown Data by Type
10.2 Middle East and Africa mRNA Vaccine Breakdown Data by Application
10.3 Middle East and Africa mRNA Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa mRNA Vaccine Sales by Countries
10.3.2 Middle East and Africa mRNA Vaccine Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of mRNA Vaccine
11.1.4 mRNA Vaccine Product Introduction
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of mRNA Vaccine
11.2.4 mRNA Vaccine Product Introduction
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of mRNA Vaccine
11.3.4 mRNA Vaccine Product Introduction
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of mRNA Vaccine
11.4.4 mRNA Vaccine Product Introduction
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of mRNA Vaccine
11.5.4 mRNA Vaccine Product Introduction
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of mRNA Vaccine
11.6.4 mRNA Vaccine Product Introduction
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of mRNA Vaccine
11.7.4 mRNA Vaccine Product Introduction
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of mRNA Vaccine
11.8.4 mRNA Vaccine Product Introduction
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of mRNA Vaccine
11.9.4 mRNA Vaccine Product Introduction
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of mRNA Vaccine
11.10.4 mRNA Vaccine Product Introduction
11.10.5 Tiba Biotechnology Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 mRNA Vaccine Sales Channels
12.2.2 mRNA Vaccine Distributors
12.3 mRNA Vaccine Customers
13 Market Forecast
13.1 Global mRNA Vaccine Sales and Revenue Forecast 2018-2025
13.2 Global mRNA Vaccine Sales Forecast by Type
13.3 Global mRNA Vaccine Sales Forecast by Application
13.4 mRNA Vaccine Forecast by Regions
13.4.1 Global mRNA Vaccine Sales Forecast by Regions 2018-2025
13.4.2 Global mRNA Vaccine Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America mRNA Vaccine Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe mRNA Vaccine Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific mRNA Vaccine Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America mRNA Vaccine Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa mRNA Vaccine Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology
【免責事項】
https://www.globalresearch.jp/disclaimer